Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas

By von Mehren M.  

Sarcoma, Vol. 8, Iss. 4, 2004-12 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

Dimeric Approaches to Anti-Cancer Chemotherapeutics

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-01 ,pp. : 807-816

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin

By Ma Rundi   Song Gang   You Wenbing   Yu Lijian   Su Weiming   Liao Mingneng   Zhang Yongping   Huang Laizhen   Zhang Xiaoyu   Yu Tingxi  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 559-568

Springer Publishing Company

Access to resources Recommend Favorite

Small-molecule inhibitors of proteins involved in base excision repair potentiate the anti-tumorigenic effect of existing chemotherapeutics and irradiation

By Reed April M   Fishel Melissa L   Kelley Mark R  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 713-726

Future Medicine

Access to resources Recommend Favorite

SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 877-881

Spandidos Publications

Access to resources Recommend Favorite